Carol Webb serves as Executive at Citius Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Carol Webb has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 19, 2025 involved receiving (via award) 300,000 shares valued at $0.
Carol Webb currently holds 300,000 shares of Citius Pharmaceuticals, Inc. (CTXR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Carol Webb has been a net neutral trader of CTXR stock. They have purchased $0 and sold $0 worth of shares.
Carol Webb's most recent insider trade was on Sep 19, 2025, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 19, 2025 | CTOR | $0 | Award | 300,000 | $N/A | Discretionary |
| Mar 4, 2024 | CTXR | $182 | Payment | 236 | $0.77 | Discretionary |
| Mar 4, 2024 | CTXR | $241 | Option Exercise | 12,071 | $0.02 | Discretionary |